Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-060790

Chief R&D Officer acquired 40,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zalevsky Jonathan · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-12 Grant or award : show line 1 in the form +40,150 331,847 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2019-12-12 Grant or award : show line 2 in the form Stock Option +71,550 71,550 D
2019-12-12 Grant or award : show line 3 in the form Stock Option +20,100 20,100 D
Loading xslF345X03/doc4.xml…